Clinical Trial Update: Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paclitaxel plus estramustine for metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Estramustine (estramustine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED